All lobbying filings

RED+BLUE STRATEGIES

Lobbying for GENEDX, LLC · Health Care Diagnostics

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 20, 2026

Income

$80,000.00

What the client paid this registrant for the period.

Client based in

Connecticut

Official filing document

Government bodies contacted 3

Food & Drug Administration (FDA)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 4709
Newborn Screening Saves Lives Reauthorization Act of 2025

Lobbying activity 2

Health Issues

H. R. 4709 - Newborn Screening Saves Lives Act of 2025 - Support for advancing 21st century genetic screenings protocols for newborns and their families. Issues related to access and affordability for pediatric genetic tests for children and families nationwide.

Medicare/Medicaid

Issues related to access and affordability for pediatric genetic tests for families with Medicaid and Marketplace coverage.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.